419
Views
15
CrossRef citations to date
0
Altmetric
Review

Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management

, , , &
Pages 883-894 | Received 11 Apr 2017, Accepted 26 Jul 2017, Published online: 03 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Leslie Citrome, Stuart H Isaacson, Danielle Larson & Daniel Kremens. (2021) Tardive Dyskinesia in Older Persons Taking Antipsychotics. Neuropsychiatric Disease and Treatment 17, pages 3127-3134.
Read now
Antonio L. Teixeira, Luiz P. Vasconcelos, Maria do Carmo Pereira Nunes & Harvey Singer. (2021) Sydenham’s chorea: from pathophysiology to therapeutics. Expert Review of Neurotherapeutics 21:8, pages 913-922.
Read now

Articles from other publishers (13)

Kadir Uludag, Dong Mei Wang, Colin Goodman, Da Chun Chen, Li Wang & Xiangyang Zhang. (2021) Prevalence, clinical correlates and risk factors associated with Tardive Dyskinesia in Chinese patients with schizophrenia. Asian Journal of Psychiatry 66, pages 102877.
Crossref
Francesco Bove, Carla Piano, Anna Rita Bentivoglio, Pietro Chiurazzi & Tommaso Tufo. (2021) Deep brain stimulation in Fragile X syndrome with tardive dystonia. Neurological Sciences 42:7, pages 2987-2989.
Crossref
Koki Nagaoka, Takuya Nagashima, Nozomi Asaoka, Hiroki Yamamoto, Chihiro Toda, Gen Kayanuma, Soni Siswanto, Yasuhiro Funahashi, Keisuke Kuroda, Kozo Kaibuchi, Yasuo Mori, Kazuki Nagayasu, Hisashi Shirakawa & Shuji Kaneko. (2021) Striatal TRPV1 activation by acetaminophen ameliorates dopamine D2 receptor antagonist–induced orofacial dyskinesia. JCI Insight 6:10.
Crossref
Stanley N. Caroff, Fan Mu, Rajeev Ayyagari, Traci Schilling, Victor Abler & Benjamin Carroll. (2020) Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia. BMC Psychiatry 20:1.
Crossref
Jeane Binotto Reinheimer, Getulio Nicola Bressan, Catiuscia Molz de Freitas, Ana Paula Chiapinotto Ceretta, Bárbara Nunes Krum, Pablo Andrei Nogara, Talita Rodrigues, Janaína Paola Schwerz, João Batista Teixeira da Rocha & Roselei Fachinetto. (2020) Effects of CATECHIN on reserpine-induced vacuous chewing movements: behavioral and biochemical analysis. Naunyn-Schmiedeberg's Archives of Pharmacology 393:12, pages 2439-2452.
Crossref
Heejin Kam & Hotcherl Jeong. (2020) Pharmacogenomic Biomarkers and Their Applications in Psychiatry. Genes 11:12, pages 1445.
Crossref
Stewart A. Factor. (2020) Management of Tardive Syndrome: Medications and Surgical Treatments. Neurotherapeutics 17:4, pages 1694-1712.
Crossref
Richard B. LiptonJoshua M. CohenSanjay K. GandhiRonghua YangPaul P. YeungDawn C. Buse. (2020) Effect of fremanezumab on quality of life and productivity in patients with chronic migraine. Neurology 95:7.
Crossref
E. E. Vaiman, N. A. Shnayder, N. G. Neznanov & R. F. Nasyrova. (2019) Antipsychotic-induced tardive dyskinesia as a serious adverse effect in the psychopharmacotherapy of schizophrenia. Neurology, Neuropsychiatry, Psychosomatics 11:4, pages 4-13.
Crossref
Laura Weiss Roberts, Robert E. Hales & Stuart C. YudofskyJames Levenson, Ericka Crouse & Kevin Bozymski. 2019. The American Psychiatric Association Publishing Textbook of Psychiatry. The American Psychiatric Association Publishing Textbook of Psychiatry.
Carlos Estevez-Fraga, Paul Zeun & Jose Luis López-Sendón Moreno. (2018) Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly. Drugs & Aging 35:11, pages 959-971.
Crossref
Mehmet Emin Demirkol, Şilan Şenbayram, Gökçen Doğangüneş & Lut Tamam. (2018) Tardif Diskinezi ve Tedavi Yaklaşımları. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry 10:2, pages 239-254.
Crossref
Klára Látalová. (2017) The issue of tardive dyskinesia, focusing on the therapeutic potential of tetrabenazine. Psychiatrie pro praxi 18:3, pages 129-132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.